Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma
Article in Blood Advances (May 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Blood Advances (May 2024)
Article in JDDG Journal der Deutschen Dermatologischen Gesellschaft (April 2024)
Article in JDDG Journal der Deutschen Dermatologischen Gesellschaft (March 2024)